Fig. 2.
Fig. 2. Complementarity determining region III (CDR III) from MCL patients undergoing BMT. VH, D, and JH regions and N-inserts from the CDR III are shown. Location of allele specific oligonucleotide (ASO) primers are shown in bold. VH, D region (where it could be identified) and JH usage for each patient is noted.

Complementarity determining region III (CDR III) from MCL patients undergoing BMT. VH, D, and JH regions and N-inserts from the CDR III are shown. Location of allele specific oligonucleotide (ASO) primers are shown in bold. VH, D region (where it could be identified) and JH usage for each patient is noted.

Close Modal

or Create an Account

Close Modal
Close Modal